Humacyte, Inc. (HUMA)
1.175
+0.06
(+4.91%)
USD |
NASDAQ |
Feb 25, 12:57
Humacyte Market Cap : 226.77M for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 974.83B |
| Hims & Hers Health, Inc. | 3.663B |
| Becton, Dickinson & Co. | 51.50B |
| ACADIA Pharmaceuticals, Inc. | 4.187B |
| Alnylam Pharmaceuticals, Inc. | 43.39B |
Market Cap Related Metrics
| PS Ratio | 107.05 |
| Price | 1.175 |
| Earnings Yield | -20.32% |